FFIV
60
2
EW
46
10
URI
30
2
BEN
36
4
MTB
44
3
OI
32
-2
SIG
41
-2
ADI
54
5
CSCO
58
-2
AMT
32
4
JWN
52
2
WMT
66
2
CSX
39
2
ACN
45
-2
PM
56
6
DRI
69
5
EQR
33
3
BAC
42
3
RCL
65
12
INTC
36
3
FFIV
60
2
EW
46
10
URI
30
2
BEN
36
4
MTB
44
3
OI
32
-2
SIG
41
-2
ADI
54
5
CSCO
58
-2
AMT
32
4
JWN
52
2
WMT
66
2
CSX
39
2
ACN
45
-2
PM
56
6
DRI
69
5
EQR
33
3
BAC
42
3
RCL
65
12
INTC
36
3
Financhill
Back

ImmunityBio Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

IBRX
ImmunityBio

Last Price:
$2.81
Seasonality Move:
-12.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Hidden Stock Under $5 Holds Tech World Hostage

Click here to see more.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ImmunityBio Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.67 Buy
20-day SMA: 3.16 Sell
50-day SMA: 4.31 Sell
200-day SMA: 5.13 Sell
8-day EMA: 2.73 Buy
20-day EMA: 3.15 Sell
50-day EMA: 3.78 Sell
200-day EMA: 4.45 Sell

ImmunityBio Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 37.27 Sell
Chaikin Money Flow: 4814139 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.51 - 4.51) Sell
Bollinger Bands (100): (3.13 - 4.89) Sell

ImmunityBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for ImmunityBio Stock

Is ImmunityBio Stock a Buy?

  • ImmunityBio share price is 2.81 while IBRX 8-day simple moving average is 2.67, which is a Buy signal.
  • The stock price of IBRX is 2.81 while ImmunityBio 20-day SMA is 3.16, which makes it a Sell.
  • ImmunityBio 50-day simple moving average is 4.31 while IBRX share price is 2.81, making it a Sell technically.
  • IBRX stock price is 2.81 and ImmunityBio 200-day simple moving average is 5.13, creating a Sell signal.

IBRX Technical Analysis vs Fundamental Analysis

Sell
30
ImmunityBio (IBRX) is a Sell

Is ImmunityBio a Buy or a Sell?

  • ImmunityBio stock is rated a Sell
    The current ImmunityBio [IBRX] share price is $2.81. The Score for IBRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.

ImmunityBio Stock Info

Market Cap:
2B
Price in USD:
2.81
Share Volume:
4.8M

ImmunityBio 52-Week Range

52-Week High:
10.53
52-Week Low:
2.50
Sell
30
ImmunityBio (IBRX) is a Sell

ImmunityBio Share Price Forecast

  • What is the ImmunityBio stock price today?
    The ImmunityBio stock price is 2.81 USD today.
  • Will IBRX stock go up or go down?
    ImmunityBio> share price is forecast to RISE/FALL based on technical indicators
  • Is ImmunityBio overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio is overvalued.

Is ImmunityBio Stock a Buy?

  • ImmunityBio share price is 2.81 while IBRX 8-day exponential moving average is 2.73, which is a Buy signal.
  • The stock price of IBRX is 2.81 while ImmunityBio 20-day EMA is 3.15, which makes it a Sell.
  • ImmunityBio 50-day exponential moving average is 3.78 while IBRX share price is 2.81, making it a Sell technically.
  • IBRX stock price is 2.81 and ImmunityBio 200-day simple moving average is 4.45, creating a Sell signal.

Fundamental Analysis of ImmunityBio

Is ImmunityBio a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.27 per share.

Technical Analysis of ImmunityBio

Should I short ImmunityBio stock?

* ImmunityBio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.